Faculty

Institution

Unit

Venue

Maryam Buni, MD

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Rheumatology

The University of Texas MD Anderson Cancer Center

Maryam Buni, Md is currently serving as a Rheumatology Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Maryam Buni, MD

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

immunology medicine oncology pharmacology rheumatology cancer immunotherapy immunotherapy cancer treatment autoimmune diseases leukemia health sciences cancer research clinical rheumatology cancer care medicinal research pharmacotherapy cytokines immune checkpoint inhibitors selective immune suppression neuromuscular medicine learning sciences musculoskeletal disorders rheumatism jama oncology arthritis experimental medicine molecular cancer cancer cells oncogenes bone marrow transplantation systemic scleroderma hand therapy cancer management patient education immunotoxicology genitourinary cancers prospective cohort studies cohort studies chronic inflammation clinical immunology therapeutic efficacy anti-inflammatory blood transfusion anti-cancer agents melanoma immunosuppressive therapy immunosuppression immunologic diseases hematological malignancies myeloid neoplasia immune-related adverse events pre-existing autoimmune disease single agent pre-existing autoimmune diseases diaphragmatic myopathy associated renal cell carcinoma early disease cohort perceived functional status early systemic sclerosis prospective longitudinal study inflammatory arthritis cancer therapy author correction immune hallmarks concomitant myeloproliferative neoplasms

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characteristics and Outcomes for Patients With Concomitant Myeloproliferative Neoplasms (Mpn) and Autoimmune Disorders. Blood (2025)

immunologic diseasespathologyautoimmune disordersimmunologyhematological malignancieshematologyimmunotherapybone marrow transplantationmedicineautoimmune diseasesconcomitant myeloproliferative neoplasmsautoimmunityleukemiaoncologymyeloid neoplasia

Author Correction: Distinct Molecular and Immune Hallmarks of Inflammatory Arthritis Induced by Immune Checkpoint Inhibitors for Cancer Therapy. Nature Communications (2024)

Sang T. KimYanshuo ChuMercy MisoiMaria E. Suarez-AlmazorJean H. TayarHuifang LuMaryam BuniJordan KramerEmma RodriguezZulekha HussainSattva S. NeelapuJennifer WangAmishi Y. ShahNizar M. TannirMatthew T. CampbellDon L. GibbonsTina CasconeCharles LuGeorge R. BlumenscheinMehmet AltanBora LimVincente ValeroMonica E. LoghinJanet TuShannon N. WestinAung NaingGuillermo Garcia-ManeroNoha Abdel-WahabHussein A. TawbiPatrick HwuIsabella C. Glitza OlivaMichael A. DaviesSapna P. PatelJun ZouAndrew FutrealAdi DiabLinghua WangRoza Nurieva

anti-inflammatoryimmunologyinflammatory arthritispharmacologyclinical immunologycancer immunotherapychronic inflammationcancer therapyimmunotherapycancer researchpharmacotherapycancer treatmentmedicinal researchimmune hallmarkscancer careclinical rheumatologyoncologyrheumatologyauthor correctionmedicineexperimental medicinetherapeutic efficacy

Diaphragmatic Myopathy Associated With Dual Immune Checkpoint Inhibitors in a Patient With Renal Cell Carcinoma. Journal of Immunotherapy and Precision Oncology (2024)

renal cell carcinomapathologykidney cancercancer immunotherapyimmunotherapygenitourinary cancersjama oncologymedicineurologydiaphragmatic myopathy associatedcancer treatmentimmune checkpoint inhibitorsoncology

Management of Hemolytic Transfusion Reactions in a Patient With Chronic Myelomonocytic Leukemia and Rare Antibodies: A Case Report. Leukemia Research Reports (2024)

immunologyhematologymedicineblood transfusionleukemia

Learning Needs of Patients With Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors. Cancers (2023)

Maria A. Lopez-OlivoJohncy J. KachiraMaryam BuniSang Taek KimHuifang LuJean H. TayarGabrielle F. DuhonJuan I. RuizClifton O. BinghamCassandra CalabreseRobert J. VolkMaria E. Suarez-Almazor

pre-existing autoimmune diseasecancer carepatient educationcancer immunotherapyimmunologylearning sciencescancer researchmedicineautoimmune diseasescancer managementcancer treatmentleukemiahealth sciencesoncology

Safety and Effectiveness of Combination Versus Monotherapy With Immune Checkpoint Inhibitors in Patients With Preexisting Autoimmune Diseases. OncoImmunology (2023)

Pankti ReidSabina SandigurskyJuhee SongMaria A. Lopez-OlivoHoussein SafaSamuel CytrynElizaveta EfuniMaryam BuniAnna PavlickMichelle KrogsgaardOsama Abu-ShawerMehmet AltanJeffrey S. WeberOsama E. RahmaMaria E. Suarez-AlmazorAdi DiabNoha Abdel-Wahab

medicineimmunologypharmacologyrheumatology

Selective Immune Suppression Using Interleukin-6 Receptor Inhibitors for Management of Immune-Related Adverse Events. Journal for ImmunoTherapy of Cancer (2023)

Faisal Fa'akMaryam BuniAdewunmi FalohunHuifang LuJuhee SongDaniel H JohnsonChrystia M ZobniwVan A TrinhMuhammad Osama AwiwiNourel Hoda TahonKhaled M ElsayesKaysia LudfordEmma J MontazariJulia ChernisMaya DimitrovaSabina SandigurskyJeffrey A SparksOsama Abu-ShawerOsama RahmaUma ThanarajasingamAshley M ZemanRafee TalukderNamrata SinghSarah H ChungPetros GrivasMay DaherAla AbudayyehIman OsmanJeffrey WeberJean H TayarMaria E Suarez-AlmazorNoha Abdel-WahabAdi Diab

selective immune suppressioncancer immunotherapyimmunologyimmunotherapypharmacologyimmune-related adverse eventscancer treatmentcytokines

816 Selective Immune Suppression Using Interleukin-6 Blockade in Immune Related Adverse Events. Regular and Young Investigator Award Abstracts (2021)

Faisal Fa'akChrystia M. ZobniwMaryam BuniLinda LuAdewunmi FalohunVanAnh TrinhMuhammad Osama AwiwiKhaled M ElsayesKaysia LudfordMaya DimitrovaSabina SandigurskyAmy Cunningham-BusselJeffrey A. SparksOsama Abu-ShawerUma ThanarajasingamAshley M. ZemanRafee TalukderNamrata SinghSarah H. ChungPetros GrivasMay DaherAla AbudayyehDaniel JohnsonMaria Suarez-AlmazorOsama E. RahmaJeffrey S. WeberJean TayarAdi DiabNoha Abdel-Wahab

immunologyselective immune suppressiononcologycytokines

Predictors of Perceived Functional Status in Early Systemic Sclerosis: A Prospective Longitudinal Study of an Early Disease Cohort. Arthritis Care & Research (2021)

Julia ChernisMaryam BuniSarah KazzazJun YingMarka LyonsShervin AssassiMaureen Mayes

prospective cohort studiesneurologychronic diseasescohort studiesarthritisrheumatologyperceived functional statusmedicineearly systemic sclerosisclinical researchprospective longitudinal studyearly disease cohorthealth sciences

657 Interleukin-6 Receptor Blockade for Management of Immune Checkpoint Inhibitor Related Adverse Events in Patients With Melanoma. Regular and Young Investigator Award Abstracts (2020)

Chantal SaberianFaisal Fa’akJean TayarMaryam BuniSang KimHuifang LuMaria Suarez-AlmazorStephen GruschkusMay DaherKaysia LudfordDaniel JohnsonNoha Abdel-WahabAdi Diab

oncogenescancer cellsimmunosuppressiontumor biologyanti-cancer agentscancer immunotherapyimmunologymedicinal researchmelanomaimmunotherapymolecular cancerimmune responsesmedicineimmunosuppressive therapysystems biologypharmacotherapyimmune checkpoint inhibitorsoncology

1
2
10 / page

Maryam Buni, MD

Associate Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Rheumatology

The University of Texas MD Anderson Cancer Center

Maryam Buni, Md is currently serving as a Rheumatology Associate Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Maryam Buni, MD

The University of Texas MD Anderson Cancer Center

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Characteristics and Outcomes for Patients With Concomitant Myeloproliferative Neoplasms (Mpn) and Autoimmune Disorders. Blood (2025)

Author Correction: Distinct Molecular and Immune Hallmarks of Inflammatory Arthritis Induced by Immune Checkpoint Inhibitors for Cancer Therapy. Nature Communications (2024)

Diaphragmatic Myopathy Associated With Dual Immune Checkpoint Inhibitors in a Patient With Renal Cell Carcinoma. Journal of Immunotherapy and Precision Oncology (2024)

Management of Hemolytic Transfusion Reactions in a Patient With Chronic Myelomonocytic Leukemia and Rare Antibodies: A Case Report. Leukemia Research Reports (2024)

immunologyhematologymedicineblood transfusionleukemia

Learning Needs of Patients With Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors. Cancers (2023)

Maria A. Lopez-OlivoJohncy J. KachiraMaryam BuniSang Taek KimHuifang LuJean H. TayarGabrielle F. DuhonJuan I. RuizClifton O. BinghamCassandra CalabreseRobert J. VolkMaria E. Suarez-Almazor

Safety and Effectiveness of Combination Versus Monotherapy With Immune Checkpoint Inhibitors in Patients With Preexisting Autoimmune Diseases. OncoImmunology (2023)

medicineimmunologypharmacologyrheumatology

Selective Immune Suppression Using Interleukin-6 Receptor Inhibitors for Management of Immune-Related Adverse Events. Journal for ImmunoTherapy of Cancer (2023)

selective immune suppressioncancer immunotherapyimmunologyimmunotherapypharmacologyimmune-related adverse eventscancer treatmentcytokines

816 Selective Immune Suppression Using Interleukin-6 Blockade in Immune Related Adverse Events. Regular and Young Investigator Award Abstracts (2021)

immunologyselective immune suppressiononcologycytokines

Predictors of Perceived Functional Status in Early Systemic Sclerosis: A Prospective Longitudinal Study of an Early Disease Cohort. Arthritis Care & Research (2021)

Julia ChernisMaryam BuniSarah KazzazJun YingMarka LyonsShervin AssassiMaureen Mayes

657 Interleukin-6 Receptor Blockade for Management of Immune Checkpoint Inhibitor Related Adverse Events in Patients With Melanoma. Regular and Young Investigator Award Abstracts (2020)

Chantal SaberianFaisal Fa’akJean TayarMaryam BuniSang KimHuifang LuMaria Suarez-AlmazorStephen GruschkusMay DaherKaysia LudfordDaniel JohnsonNoha Abdel-WahabAdi Diab

1
2
10 / page